Progress in care and enhanced treatment alternatives have decreased the peril of long-term problems and death for above 25 Million individuals who have diabetes and are typified by high blood sugar. Concurrently, patients at times experience hazardously low levels of blood sugar while having diabetes medications, particularly after exercising harder than normal or omitting a meal.
A research team has designed a tool for recognizing diabetes patients who are at the greater risk for being hospitalized owing to very low level of blood sugar. Andrew J Karter of the Kaiser Permanente Division of Research said, “At times, an individual with diabetes is not aware that their blood sugar is plummeting and can progress rapidly into severe hypoglycemia that has been linked to automobile accidents, falls, coma, heart attacks, and even death.”
He further said, “Often, hypoglycemia is avoidable with the appropriate clinical care, and we consider this tool will aid in focusing that attention on the individuals who most require it.” The team designed the hypoglycemia risk stratification device by spotting 156 likely risk causes for hypoglycemia and gathering information from above 200,000 individuals with type II diabetes.
With the use of machine-learning analytical methods, they developed a prototype to estimate a 12-month risk of a patient for hypoglycemia-associated emergency section or hospital use. The ultimate model was anchored on 6 variables, namely, use of insulin; digit of previous episodes of hypoglycemia-related hospitalizations; use of sulfonylurea; severe kidney disease; age; and figure of emergency visits for any cause in the previous year.
On the basis of the model, the team developed a practical tool to classify patients into low (<1%), intermediate (1–5%), or high (>5%) annual risk of hypoglycemia-associated emergency section or hospital use. Researchers said, “The tool was then authenticated with information from above 1.3 Million individuals of the US Veterans Health Administration and around 15,000 Kaiser Permanente associates in Washington State with type II diabetes.”
Numerous private and public health care organizations and systems, including the Mayo Clinic, Kaiser Permanente, and CMS, are now probing how they can utilize the tool to augment alertness about hypoglycemia and help individuals with type II diabetes shun risky events in the future.